Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

Area of Science:

• Cardiovascular Biology
• Protease Biochemistry
• Cellular Signaling

Background:

• Matrix metalloproteinase-2 (MMP-2) is a zinc-dependent protease known for degrading extracellular matrix proteins.
• Elevated MMP-2 activity is linked to myocardial ischemia, reperfusion injury, and heart failure progression, primarily in cardiac remodeling.
• Conventional understanding limits MMP-2's role to extracellular matrix proteolysis.

Purpose of the Study:

• To review recent research on MMP-2, focusing on its non-proteolytic activation pathways under oxidative stress.
• To explore the intracellular actions of MMP-2 within cardiomyocytes and its role in acute contractile dysfunction.
• To discuss the regulation of MMP-2, including expression, post-translational modifications, and inhibition.

Main Methods:

• Literature review of recent studies on MMP-2 activation and function.
• Analysis of evidence for MMP-2's intracellular localization and targets within cardiomyocytes.
• Examination of regulatory mechanisms including tissue inhibitors of metalloproteinases (TIMPs), caveolin, and small molecule inhibitors.

Main Results:

• MMP-2 is increasingly recognized for intracellular actions within cardiomyocytes, not just extracellular matrix degradation.
• Oxidative stress can activate MMP-2 via non-proteolytic pathways, leading to acute, reversible contractile dysfunction.
• MMP-2 proteolyzes specific intracellular protein targets, impacting cardiomyocyte function.

Conclusions:

• MMP-2 is an emerging signaling protease involved in myocardial oxidative stress injury.
• Intracellular MMP-2 activity challenges the traditional view of its function, highlighting its role in regulating cardiomyocyte proteins.
• Understanding MMP-2's multifaceted roles is crucial for developing therapeutic strategies for heart conditions.